siRNA targeting of mitochondrial thymidine kinase 2 (TK2) sensitizes cancer cells to gemcitabine and increases mitochondrial toxicity

被引：0
|
作者：
Di Cresce, C. [1 ]
Ferguson, P. [2 ]
Figueredo, R. [2 ]
Rytelewski, M. [1 ]
Vareki, S. Maleki [1 ]
Vincent, M. D. [1 ]
Koropatnick, J. [1 ]
机构：
[1] Univ Western Ontario, London, ON, Canada
[2] London Reg Canc Ctr, Canc Res Labs, London, ON N6A 4L6, Canada
来源：
EUROPEAN JOURNAL OF CANCER | 2014年 / 50卷
关键词：
D O I：
10.1016/S0959-8049(14)70175-3
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
49
引用
收藏
页码：21 / 21
页数：1
相关论文
共 50 条
  • [41] Selective muscle fiber loss and molecular compensation in mitochondrial myopathy due to TK2 deficiency
    Vila, Maya R.
    Villarroya, Joan
    Garcia-Arumi, Elena
    Castellote, Amparo
    Meseguer, Anna
    Hirano, Michio
    Roig, Manuel
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2008, 267 (1-2) : 137 - 141
  • [42] Enzymatic Regulation of Cytosolic Thymidine Kinase 1 and Mitochondrial Thymidine Kinase 2: A Mini Review
    Munch-Petersen, B.
    NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS, 2010, 29 (4-6): : 363 - 369
  • [43] Biochemistry and Biology of 2'-Fluoro-2'-Deoxythymidine (FT), A Putative Highly Selective Substrate for Thymidine Kinase Type 2 (TK2)
    Wiebe, Leonard I.
    Sun, William
    Zhou, Aihua
    Yang, Jennifer
    Sjuvarsson, Elena V.
    Eriksson, Staffan
    Paproski, Robert J.
    Cass, Carol E.
    Kumar, Piyush
    Knaus, Edward E.
    CURRENT RADIOPHARMACEUTICALS, 2012, 5 (01) : 38 - 46
  • [44] Mitochondrial deoxyribonucleoside triphosphate pools in thymidine kinase 2 deficiency
    Saada, A
    Ben-Shalom, E
    Zyslin, R
    Miller, C
    Mandel, H
    Elpeleg, O
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2003, 310 (03) : 963 - 966
  • [45] Synthesis and evaluation of thymine-derived carboxamides against mitochondrial thymidine kinase (TK-2) and related enzymes
    Priego, EM
    Balzarini, J
    Karlsson, A
    Camarasa, MJ
    Pérez-Pérez, MJ
    BIOORGANIC & MEDICINAL CHEMISTRY, 2004, 12 (19) : 5079 - 5090
  • [46] MT1621 for thymidine kinase 2 deficiency (TK2d): mechanism of action is via mitochondrial DNA incorporation
    Tsuruda, L.
    Kenny, D.
    Blazquez-Bermejo, C.
    Karlsson, A.
    Marti, R.
    Camara, Y.
    NEUROMUSCULAR DISORDERS, 2020, 30 : S139 - S139
  • [47] Combining siRNAs Targeting Thymidylate Synthase and Thymidine Kinase 1 or 2 Sensitizes Human Tumor Cells to the Anticancer Drugs 5FUdR, Pemetrexed and Gemcitabine
    Di Cresce, C.
    Figueredo, R.
    Ferguson, P. J.
    Vincent, M. D.
    Koropatnick, J.
    EUROPEAN JOURNAL OF CANCER, 2012, 48 : 58 - 58
  • [48] New mutation in thymidine kinase 2 gene associated with mitochondrial encephalomyopathy
    Galbiati, S
    Papadimitriou, D
    Bordoni, A
    Crimi, M
    Katsarou, E
    Garoufi, A
    Bresolin, N
    Papadimitriou, A
    Comi, GP
    JOURNAL OF NEUROLOGY, 2004, 251 : 173 - 173
  • [49] Identification and Characterization of Mitochondrial Factors Modulating Thymidine Kinase 2 Activity
    Sun, R.
    Eriksson, S.
    Wang, L.
    NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS, 2010, 29 (4-6): : 382 - 385
  • [50] Mitochondrial DNA depletion syndrome and new mutations in thymidine kinase 2 and deoxyguanosine kinase
    Mancuso, M
    Sacconi, S
    Salviati, L
    Bonilla, E
    Hirano, M
    Vu, TH
    Di Mauro, S
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2002, 199 : S87 - S87
12345